ACE2 and COVID-19: The reported increased expression of ACE2 in an experimental model of Duchenne muscular dystrophy (DMD) [114], in which RAGE is also expressed and chronically stimulated [115], points to a susceptibility of DMD muscles to SARS-CoV-2 infection, and the vulnerability of DMD patients to accelerated muscle wasting when affected by COVID-19.